Molecular Vaccines

1. Front Matter

   Pages i-xxviii

   PDF

2. Noninfectious and Noncancer (NINC) Vaccines

   1. Front Matter

      Pages 449-450

      PDF

   2. Vaccines for Hypertension and Atherosclerosis

      • Hiroyuki Sasamura, Tasuhiko Azegami, Hiroshi Itoh

      Pages 451-461

   3. Anti-ghrelin Therapeutic Vaccine: A Novel Approach for Obesity Treatment

      • Sara Andrade, Marcos Carreira, Felipe F. Casanueva, Polly Roy, Mariana P. Monteiro

      Pages 463-476

   4. Vaccines for Type 1 Diabetes

      • Sandeep Kumar Gupta

      Pages 477-488

   5. Novel Vaccines for Type I Allergy

      • Sandra Scheiblhofer, Josef Thalhamer, Richard Weiss

      Pages 489-501

   6. Rice Seed-Based Allergy Vaccines: Induction of Allergen-Specific Oral Tolerance Against Cedar Pollen and House Dust Mite Allergies

      • Fumio Takaiwa, Takachika Hiroi

      Pages 503-516

3. Adjuvants and Nanotechnology

   1. Front Matter

      Pages 517-518

      PDF

   2. Laser for Skin Vaccine Delivery and Adjuvantation

      • Xinyuan Chen, Mei X. Wu

      Pages 519-525

   3. Bacterial Lipopolysaccharide as Adjuvants

      • Jesús Arenas

      Pages 527-536

   4. Bacterial Toxins Are Successful Immunotherapeutic Adjuvants and Immunotoxins

      • Irena Adkins

      Pages 537-549

   5. Plant Heat-Shock Protein-Based Self-Adjuvanted Immunogens

      • Selene Baschieri

      Pages 551-560

   6. Functionalised Nanoliposomes for Construction of Recombinant Vaccines: Lyme Disease as an Example

      • Jaroslav Turánek, Josef Mašek, Michal Křupka, Milan Raška

      Pages 561-577

   7. Emerging Nanotechnology Approaches for Pulmonary Delivery of Vaccines

      • Amit K. Goyal, Goutam Rath, Basant Malik

      Pages 579-601

   8. Antigen Delivery Systems as Oral Adjuvants

      • Carlos Gamazo, Juan M. Irache

      Pages 603-622

   9. Chitosan-Based Adjuvants

      • Guro Gafvelin, Hans Grönlund

      Pages 623-631

   10. Mechanism of Adjuvanticity of Aluminum-Containing Formulas

       • Mirjam Kool, Bart N. Lambrecht

       Pages 633-642

   11. From Polymers to Nanomedicines: New Materials for Future Vaccines

       • Philipp Heller, David Huesmann, Martin Scherer, Matthias Barz

       Pages 643-671

4. In Silico and Delivery Systems

   1. Front Matter

      Pages 673-675

      PDF

   2. Considerations for Vaccine Design in the Postgenomic Era

      • Christine Maritz-Olivier, Sabine Richards

      Pages 677-696

This title discusses all aspects of non-infectious and non-cancer– so called NINC – vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.

• cell vaccines
• delivery systems
• prophyalxis and therapy
• vaccine adjuvants
• vaccine tools
• vaccines

• Institute for Molecular Vaccines, Heidelberg, Germany

  Matthias Giese

Dr. Matthias Giese, Heidelberg, Germany

Policies and ethics